General Announcement::Press Release

Issuer & Securities

Issuer/ Manager
BIOCON BIOLOGICS GLOBAL PLC
Securities
BIOCONBIO US$800M6.67%N291009A - US090978AA56 - RJUB
BIOCONBIO US$800M6.67%N291009R - USG11185AA61 - KSEB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
13-Dec-2025 16:35:04
Status
New
Announcement Sub Title
Press Release
Announcement Reference
SG251213OTHR2X4Z
Submitted By (Co./ Ind. Name)
Biocon Biologics Limited/ Akhilesh Nand
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Press release on Biocon Biologics Signs Settlement and License Agreement to Commercialize Biosimilar Aflibercept Worldwide

Attachments

BBL_Aflibercept_Settlement_SGX.pdf
Total size =270K